Part 9 of a series on global health at Duke: By: Linda George. Our planet is graying. In every major society today, there are ever-increasing numbers and proportions of people over the age of 65. Indeed, the fastest growing segment of most societies is now the “oldest old”-individuals who are 85 and older.
On Nov. 30, the Duke Global Health Student Action Committee (GHSAC), an official Duke student body organization affiliated with the Duke Global Health Institute, arranged the opportunity for more than a dozen students to have lunch with the influential Namibian AIDS activist Anita Isaacs. On Dec. 2, the group hosted a global health forum to which more than 50 students came to learn about opportunities in global health for students.
Jeffrey Moe, professor in the Health Sector Management program at Duke’s Fuqua School of Business, takes a look at neglected diseases through the lens of business in the eighth article the Duke Chronicle’s series on global health.
Researchers at Duke and other centers world-wide have found that eltrombopag (marketed as Promacta in the US and Revolade in Europe) boosted platelet counts in a majority of patients with low platelet counts and cirrhosis of the liver due to hepatitis C virus infection. Higher platelet counts enabled most patients to continue or start conventional antiviral treatment. Unlike other drugs that restore normal platelet functions but are given through infusions or injections, eltrombopag is a pill taken just once a day.
Led by Michael Merson, MD, the institute is built on collaboration among researchers from schools and departments throughout Duke University in an effort to combat global health problems like HIV/AIDS and cancer and to address the economic, social, environmental, and political issues associated with global healthcare.
More than $45,000 in funding recently was awarded to Duke faculty and staff who submitted proposals earlier in the semester to the Duke Center for Civic Engagement (DCCE) to explore sites around the globe as potential DukeEngage programs in the coming years.
Michael Merson, M.D., director of the Duke Global Health Institute, has agreed to serve as chairman of the MIDAS Steering Committee starting with the May 2008 meeting.
In the middle of a Venn diagram where human health concerns like cancer, diabetes and asthma meet real-world environmental conditions like water pollution, lead paint and social stress, a growing collaboration of Duke researchers have begun digging.
Duane Gubler, an internationally recognized expert on dengue fever, has taken on the post of Director – Emerging Infectious Diseases research program at the Duke-NUS Graduate Medical School in Singapore. His appointment was effective Nov. 1, 2007.
Phil Costanzo writes Duke ChroniclePart 7 in a series on global health in the Duke Chronicle. Obesity is an important focus of global health efforts today because it is a premorbid state that can be preventable with increases in our scientific understanding of the sources of its “spread.”